Phase I Universal Flu Vaccine Trial Begins!

by | Jun 29, 2022 | Public Health, Research | 0 comments

US Stats News reports that the new influenza vaccine has started an important trial. The placebo-controlled study at the National Institutes of Health Clinical Center in Bethesda, Maryland will test its safety and whether it can stimulate an immune response in healthy adults aged 18 – 55 years old led by Matthew J Memoli MD researcher from NIAID’s single-site research team!

Potential Universal Flu Vaccine

Scientists are getting closer than ever to a universal flu vaccine. This cocktail has already gone through animal testing and is slated to begin Phase I clinical trials this month. The vaccine so far looks very promising. This is a game-changer!

“The scientific community is making progress on this pressing global health priority. The BPL-1357 candidate influenza vaccine being tested in this clinical trial performed very well in pre-clinical studies and we look forward to learning how it performs in people.”

NIAID Director Anthony S. Fauci, M.D.


Learn How Clinical Trials Work

Clinical trials can be confusing and overwhelming, especially if you’re not familiar with the terminology.

You may have seen commercials for clinical trials on TV and wondered what they are and how you can get involved.

This course is designed to help beginners understand everything about clinical trials, from what they are to how you can participate. We’ll walk you through 7 easy steps that will make the process simple and straightforward. We use the Pfizer COVID Vaccine as an example of how clinical trials work.

Online Jewelry Store is Giving Back

Or you can buy here. Choose your favorite jewelry. Make a purchase, and aNecklaceForMe will ensure 1% goes directly to women living in poverty.

Powered By MemberPress WooCommerce Plus Integration